Form 4 for FENC FENNEC PHARMACEUTICALS INC.
Accepted 2026-03-03 00:00:00 ET · period of report 2026-02-28 · accession 0001468316-26-000008 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-03-03 | 2026-03-02 | FENC | Raykov Rosty | Dir | M - OptEx | $2.45 | +15.6K | 114.1K | +16% | +$38.2K |
| D | 2026-03-03 | 2026-03-02 | FENC | Raykov Rosty | Dir | S - Sale+OE | $8.36 | -10.1K | 104.0K | -9% | -$84.3K |
| D | 2026-03-03 | 2026-02-28 | FENC | Raykov Rosty | Dir | A - Grant | $0.00 | +5,208 | 109.2K | +5% | $0 |
| D | 2026-03-03 | 2026-03-02 | FENC | Raykov Rosty | Dir | M - OptEx | $2.45 | -15.6K | 1.59M | -1.0% | -$38.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common shares | 2026-03-02 | M | A | 15,598 | $2.45 | 114,075 | D | — | — | (F1) Shares acquired through the exercise of an option pursuant to a 10b5-1 plan adopted on September 19, 2025. |
| 2 | Common | Common shares | 2026-03-02 | S | D | 10,079 | $8.36 | 103,996 | D | — | — | (F2) Shares sold to satisfy tax obligation on option exercise. |
| 3 | Common | Common shares | 2026-02-28 | A | A | 5,208 | $0.00 | 109,204 | D | — | — | (F3) Represents shares released from restriction from shares awarded 3/31/2023 and 5/16/2024. |
| 4 | Derivative | Stock Options | 2026-03-02 | M | D | 15,598 | $2.45 | 1,587,390 | D | $2.45 · 2016-07-05 to 2026-07-05 | 15,598 options | (F4) Represents options exercised pursuant to a 10b5-1 plan adopted on September 19, 2025. |